Cargando…
Integrated bioinformatics analysis of potential biomarkers for pancreatic cancer
BACKGROUND: Pancreatic cancer, particularly pancreatic ductal adenocarcinoma (PDA), is an aggressive malignancy associated with a low 5‐year survival rate. Poor outcomes associated with PDA are attributable to late detection and inoperability. Most patients with PDA are diagnosed with locally advanc...
Autores principales: | Shi, Huaqing, Xu, Hao, Chai, Changpeng, Qin, Zishun, Zhou, Wence |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9102654/ https://www.ncbi.nlm.nih.gov/pubmed/35403252 http://dx.doi.org/10.1002/jcla.24381 |
Ejemplares similares
-
A nomogram for predicting survival in patients with advanced (stage III/IV) pancreatic body tail cancer: a SEER-based study
por: Shi, Huaqing, et al.
Publicado: (2022) -
Immunocyte Infiltration Analysis and Immunohistochemistry Identify EVL as a Potential Prognostic Biomarker for Pancreatic Cancer
por: Du, Yan, et al.
Publicado: (2023) -
Nomograms for Predicting the Risk and Prognosis of Liver Metastases in Pancreatic Cancer: A Population-Based Analysis
por: Shi, Huaqing, et al.
Publicado: (2023) -
Identification and Verification of Potential Biomarkers in Gastric Cancer By Integrated Bioinformatic Analysis
por: Sun, Chenyu, et al.
Publicado: (2022) -
Integrated bioinformatics analysis shows integrin alpha 3 is a prognostic biomarker for pancreatic cancer
por: Hu, Fangfang, et al.
Publicado: (2022)